{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T11:09:38Z","timestamp":1760267378294},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,5,14]],"date-time":"2015-05-14T00:00:00Z","timestamp":1431561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2015,5,14]],"date-time":"2015-05-14T00:00:00Z","timestamp":1431561600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arthritis Res Ther"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                        <jats:title>Introduction<\/jats:title>\n                        <jats:p>Impairment in the ability of the inflamed synovium to generate cortisol has been proposed to be a factor in the persistence and severity of inflammatory arthritis. In the inflamed synovium, cortisol is generated from cortisone by the 11\u03b2-hydroxysteroid dehydrogenase type 1 (11\u03b2-HSD1) enzyme. The objective of this study was to determine the role of endogenous glucocorticoid metabolism in the development of persistent inflammatory arthritis.<\/jats:p>\n                     <\/jats:sec><jats:sec>\n                        <jats:title>Methods<\/jats:title>\n                        <jats:p>Urine samples were collected from patients with early arthritis (symptoms \u226412\u00a0weeks duration) whose final diagnostic outcomes were established after clinical follow-up and from patients with established rheumatoid arthritis (RA). All patients were free of disease-modifying anti-rheumatic drugs at the time of sample collection. Systemic measures of glucocorticoid metabolism were assessed in the urine samples by gas chromatography\/mass spectrometry. Clinical data including CRP and ESR were also collected at baseline.<\/jats:p>\n                     <\/jats:sec><jats:sec>\n                        <jats:title>Results<\/jats:title>\n                        <jats:p>Systemic measures of 11\u03b2-HSD1 activity were significantly higher in patients with early arthritis whose disease went on to persist, and also in the subgroup of patients with persistent disease who developed RA, when compared with patients whose synovitis resolved over time. We observed a significant positive correlation between systemic 11\u03b2-HSD1 activity and ESR\/CRP in patients with established RA but not in any of the early arthritis patients group.<\/jats:p>\n                     <\/jats:sec><jats:sec>\n                        <jats:title>Conclusions<\/jats:title>\n                        <jats:p>The present study demonstrates that patients with a new onset of synovitis whose disease subsequently resolved had significantly lower levels of systemic 11\u03b2-HSD1 activity when compared with patients whose synovitis developed into RA or other forms of persistent arthritis. Low absolute levels of 11\u03b2-HSD1 activity do not therefore appear to be a major contributor to the development of RA and it is possible that a high total body 11\u03b2-HSD1 activity during early arthritis may reduce the probability of disease resolution.<\/jats:p>\n                     <\/jats:sec>","DOI":"10.1186\/s13075-015-0633-2","type":"journal-article","created":{"date-parts":[[2015,5,13]],"date-time":"2015-05-13T17:21:42Z","timestamp":1431537702000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Differential glucocorticoid metabolism in patients with persistent versus resolving inflammatory arthritis"],"prefix":"10.1186","volume":"17","author":[{"given":"Dominika E","family":"Nanus","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew D","family":"Filer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lorraine","family":"Yeo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dagmar","family":"Scheel-Toellner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rowan","family":"Hardy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gareth G","family":"Lavery","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul M","family":"Stewart","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher D","family":"Buckley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeremy W","family":"Tomlinson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark S","family":"Cooper","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karim","family":"Raza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,5,14]]},"reference":[{"key":"633_CR1","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1093\/oxfordjournals.bmb.a072973","volume":"51","author":"GS Panayi","year":"1995","unstructured":"Panayi GS. Hormonal control of rheumatoid inflammation. Br Med Bull. 1995;51:462\u201371.","journal-title":"Br Med Bull."},{"key":"633_CR2","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1136\/ard.2009.119149","volume":"69","author":"SMM Verstappen","year":"2010","unstructured":"Verstappen SMM, McCoy MJ, Roberts C, Dale NE, Hassell AB, Symmons DPM. Beneficial effects of a 3-week course of intramuscular glucocorticoid injections in patients with very early inflammatory polyarthritis: results of the STIVEA trial. Ann Rheum Dis. 2010;69:503\u20139.","journal-title":"Ann Rheum Dis."},{"key":"633_CR3","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1210\/er.2012-1050","volume":"34","author":"LL Gathercole","year":"2013","unstructured":"Gathercole LL, Lavery GG, Morgan SA, Cooper MS, Sinclair AJ, Tomlinson JW, et al. 11\u03b2-hydroxysteroid dehydrogenase 1: translational and therapeutic aspects. Endocr Rev. 2013;34:525\u201355.","journal-title":"Endocr Rev."},{"key":"633_CR4","doi-asserted-by":"publisher","first-page":"1711","DOI":"10.1002\/art.21091","volume":"52","author":"M Schmidt","year":"2005","unstructured":"Schmidt M, Weidler C, Naumann H, Anders S, Sch\u00f6lmerich J, Straub RH. Reduced capacity for the reactivation of glucocorticoids in rheumatoid arthritis synovial cells: possible role of the sympathetic nervous system? Arthritis Rheum. 2005;52:1711\u201320.","journal-title":"Arthritis Rheum."},{"key":"633_CR5","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1136\/ard.2008.090662","volume":"67","author":"R Hardy","year":"2008","unstructured":"Hardy R, Rabbitt EH, Filer A, Emery P, Hewison M, Stewart PM, et al. Local and systemic glucocorticoid metabolism in inflammatory arthritis. Ann Rheum Dis. 2008;67:1204\u201310.","journal-title":"Ann Rheum Dis."},{"key":"633_CR6","doi-asserted-by":"publisher","first-page":"R108","DOI":"10.1186\/ar1993","volume":"8","author":"RS Hardy","year":"2006","unstructured":"Hardy RS, Filer A, Cooper MS, Parsonage G, Raza K, Hardie DL, et al. Differential expression, function and response to inflammatory stimuli of 11beta-hydroxysteroid dehydrogenase type 1 in human fibroblasts: a mechanism for tissue-specific regulation of inflammation. Arthritis Res Ther. 2006;8:R108.","journal-title":"Arthritis Res Ther."},{"key":"633_CR7","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1136\/annrheumdis-2013-203926","volume":"74","author":"DE Nanus","year":"2014","unstructured":"Nanus DE, Filer AD, Hughes B, Fisher B a, Taylor PC, Stewart PM, et al. TNF\u03b1 regulates cortisol metabolism in vivo in patients with inflammatory arthritis. Ann Rheum Dis. 2014;74:464\u20139.","journal-title":"Ann Rheum Dis"},{"key":"633_CR8","first-page":"S23","volume":"29","author":"RH Straub","year":"2011","unstructured":"Straub RH, Buttgereit F, Cutolo M, Buttgereit F, Cutolo M, Heumatology EXR. Alterations of the hypothalamic-pituitary-adrenal axis in systemic immune diseases \u2013 a role for misguided energy regulation. Clin Exp Rheumatol. 2011;29:S23\u201331.","journal-title":"Clin Exp Rheumatol."},{"key":"633_CR9","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1002\/art.1780310302","volume":"31","author":"FC Arnett","year":"1988","unstructured":"Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 1988;31:315\u201324.","journal-title":"Arthritis Rheum."},{"key":"633_CR10","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1046\/j.1365-2265.1996.00853.x","volume":"45","author":"M Palermo","year":"1996","unstructured":"Palermo M, Shackleton CHL, Mantero F, Stewart PM. Urinary free cortisone and the assessment of 11beta-hydroxysteroid dehydrogenase activity in man. Clin Endocrinol (Oxf). 1996;45:605\u201311.","journal-title":"Clin Endocrinol (Oxf)."},{"key":"633_CR11","doi-asserted-by":"publisher","first-page":"2404","DOI":"10.1002\/art.34414","volume":"64","author":"MM Ahasan","year":"2012","unstructured":"Ahasan MM, Hardy R, Jones C, Kaur K, Nanus D, Juarez M, et al. Inflammatory regulation of glucocorticoid metabolism in mesenchymal stromal cells. Arthritis Rheum. 2012;64:2404\u201313.","journal-title":"Arthritis Rheum."},{"key":"633_CR12","doi-asserted-by":"publisher","first-page":"R784","DOI":"10.1186\/ar1733","volume":"7","author":"K Raza","year":"2005","unstructured":"Raza K, Falciani F, Curnow SJ, Ross EJ, Lee C-Y, Akbar AN, et al. Early rheumatoid arthritis is characterized by a distinct and transient synovial fluid cytokine profile of T cell and stromal cell origin. Arthritis Res Ther. 2005;7:R784\u201395.","journal-title":"Arthritis Res Ther."},{"key":"633_CR13","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/S0165-0173(96)00012-4","volume":"23","author":"BS McEwen","year":"1997","unstructured":"McEwen BS, Biron C, Brunson KW, Bulloch K, Chambers WH, Dhabhar FS, et al. The role of adrenocorticoids as modulators of immune function in health and disease: neural, endocrine and immune interactions. Brain Res Brain Res Rev. 1997;23:79\u2013133.","journal-title":"Brain Res Brain Res Rev."},{"key":"633_CR14","doi-asserted-by":"publisher","first-page":"3701","DOI":"10.1210\/en.2012-1020","volume":"153","author":"EA Lannan","year":"2012","unstructured":"Lannan EA, Galliher-Beckley AJ, Scoltock AB, Cidlowski JA. Proinflammatory actions of glucocorticoids: glucocorticoids and TNF\u03b1 coregulate gene expression in vitro and in vivo. Endocrinology. 2012;153:3701\u201312.","journal-title":"Endocrinology."},{"key":"633_CR15","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.bbi.2011.10.005","volume":"26","author":"MG Frank","year":"2012","unstructured":"Frank MG, Thompson BM, Watkins LR, Maier SF. Glucocorticoids mediate stress-induced priming of microglial pro-inflammatory responses. Brain Behav Immun. 2012;26:337\u201345.","journal-title":"Brain Behav Immun."},{"key":"633_CR16","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/j.intimp.2013.07.015","volume":"17","author":"L Zhang","year":"2013","unstructured":"Zhang L, Dong Y, Zou F, Wu M, Fan C, Ding Y. 11\u03b2-hydroxysteroid dehydrogenase 1 inhibition attenuates collagen-induced arthritis. Int Immunopharmacol. 2013;17:489\u201394.","journal-title":"Int Immunopharmacol."},{"key":"633_CR17","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1210\/en.2011-1398","volume":"153","author":"AE Coutinho","year":"2012","unstructured":"Coutinho AE, Gray M, Brownstein DG, Salter DM, Sawatzky DA, Clay S, et al. 11\u03b2-hydroxysteroid dehydrogenase type 1, but not type 2, deficiency worsens acute inflammation and experimental arthritis in mice. Endocrinology. 2012;153:234\u201340.","journal-title":"Endocrinology."},{"key":"633_CR18","doi-asserted-by":"publisher","first-page":"2016","DOI":"10.1093\/rheumatology\/keq212","volume":"49","author":"K Raza","year":"2010","unstructured":"Raza K, Hardy R, Cooper MS. The 11beta-hydroxysteroid dehydrogenase enzymes--arbiters of the effects of glucocorticoids in synovium and bone. Rheumatology (Oxford, England). 2010;49:2016\u201323.","journal-title":"Rheumatology (Oxford, England)"},{"key":"633_CR19","doi-asserted-by":"publisher","first-page":"e84057","DOI":"10.1371\/journal.pone.0084057","volume":"8","author":"AHM Kilgour","year":"2013","unstructured":"Kilgour AHM, Gallagher IJ, Maclullich AMJ, Andrew R, Gray CD, Hyde P, et al. Increased skeletal muscle 11\u03b2-HSD1 mRNA is associated with lower muscle strength in Ageing. PLoS One. 2013;8:e84057.","journal-title":"PLoS One."},{"key":"633_CR20","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1196\/annals.1422.036","volume":"1108","author":"Z Szekanecz","year":"2007","unstructured":"Szekanecz Z, Kerekes G, Der H, Sandor Z, Szabo Z, Vegvari A, et al. Accelerated atherosclerosis in rheumatoid arthritis. Ann N Y Acad Sci. 2007;1108:349\u201358.","journal-title":"Ann N Y Acad Sci."},{"key":"633_CR21","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1152\/physiolgenomics.00109.2012","volume":"45","author":"MJ Luo","year":"2013","unstructured":"Luo MJ, Thieringer R, Springer MS, Wright SD, Hermanowski-Vosatka A, Plump A, et al. 11\u03b2-HSD1 inhibition reduces atherosclerosis in mice by altering proinflammatory gene expression in the vasculature. Physiol Genomics. 2013;45:47\u201357.","journal-title":"Physiol Genomics."}],"container-title":["Arthritis Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-015-0633-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13075-015-0633-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-015-0633-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-015-0633-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,14]],"date-time":"2024-10-14T16:36:29Z","timestamp":1728923789000},"score":1,"resource":{"primary":{"URL":"https:\/\/arthritis-research.biomedcentral.com\/articles\/10.1186\/s13075-015-0633-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,5,14]]},"references-count":21,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2015,12]]}},"alternative-id":["633"],"URL":"https:\/\/doi.org\/10.1186\/s13075-015-0633-2","relation":{},"ISSN":["1478-6354"],"issn-type":[{"type":"electronic","value":"1478-6354"}],"subject":[],"published":{"date-parts":[[2015,5,14]]},"assertion":[{"value":"10 December 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 April 2015","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 May 2015","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"121"}}